Oreopoulos DG - Search Results

1

Peritoneal dialysis in end-stage renal disease after liver transplantation.

Shukla AM, Lobbedez T, Chu M, Izatt S, Bargman JM, Oreopoulos DG. Shukla AM, et al. Among authors: oreopoulos dg. Adv Perit Dial. 2004;20:93-7. Adv Perit Dial. 2004. PMID: 15384804

2

Normal or low initial PTH levels are not a predictor of morbidity/mortality in patients undergoing chronic peritoneal dialysis.

Dimkovic NB, Bargman J, Vas S, Oreopoulos DG. Dimkovic NB, et al. Among authors: oreopoulos dg. Perit Dial Int. 2002 Mar-Apr;22(2):204-10. Perit Dial Int. 2002. PMID: 11990405

3

Predictors of outcome following bacterial peritonitis in peritoneal dialysis.

Krishnan M, Thodis E, Ikonomopoulos D, Vidgen E, Chu M, Bargman JM, Vas SI, Oreopoulos DG. Krishnan M, et al. Among authors: oreopoulos dg. Perit Dial Int. 2002 Sep-Oct;22(5):573-81. Perit Dial Int. 2002. PMID: 12455568

4

Chiropody may prevent amputations in diabetic patients on peritoneal dialysis.

Lipscombe J, Jassal SV, Bailey S, Bargman JM, Vas S, Oreopoulos DG. Lipscombe J, et al. Among authors: oreopoulos dg. Perit Dial Int. 2003 May-Jun;23(3):255-9. Perit Dial Int. 2003. PMID: 12938826

5

Fatigue in chronic peritoneal dialysis patients.

Ossareh S, Roozbeh J, Krishnan M, Liakopoulos V, Bargman JM, Oreopoulos DG. Ossareh S, et al. Among authors: oreopoulos dg. Int Urol Nephrol. 2003;35(4):535-41. doi: 10.1023/b:urol.0000025610.67447.b9. Int Urol Nephrol. 2003. PMID: 15198163

6

Relationship between serum magnesium, parathyroid hormone, and vascular calcification in patients on dialysis: a literature review.

Wei M, Esbaei K, Bargman J, Oreopoulos DG. Wei M, et al. Among authors: oreopoulos dg. Perit Dial Int. 2006 May-Jun;26(3):366-73. Perit Dial Int. 2006. PMID: 16722031 Review.

7

Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: a contributing factor to adynamic bone disease?

Wei M, Esbaei K, Bargman JM, Oreopoulos DG. Wei M, et al. Among authors: oreopoulos dg. Int Urol Nephrol. 2006;38(2):317-22. doi: 10.1007/s11255-006-0082-6. Int Urol Nephrol. 2006. PMID: 16868704 Clinical Trial.

8

Intravenous iron does not affect the rate of decline of residual renal function in patients on peritoneal dialysis.

Shah H, Shukla A, Krishnan A, Pliakogiannis T, Ahmad M, Bargman JM, Oreopoulos DG. Shah H, et al. Among authors: oreopoulos dg. Adv Perit Dial. 2006;22:99-103. Adv Perit Dial. 2006. PMID: 16983949

9

Factors related to erythropoietin hypo-responsiveness in patients on chronic peritoneal dialysis.

Wei M, Bargman JM, Oreopoulos DG. Wei M, et al. Among authors: oreopoulos dg. Int Urol Nephrol. 2007;39(3):935-40. doi: 10.1007/s11255-007-9226-6. Epub 2007 May 30. Int Urol Nephrol. 2007. PMID: 17534732

10

High peritoneal permeability is not associated with higher mortality or technique failure in patients on automated peritoneal dialysis.

Yang X, Fang W, Bargman JM, Oreopoulos DG. Yang X, et al. Among authors: oreopoulos dg. Perit Dial Int. 2008 Jan-Feb;28(1):82-92. Perit Dial Int. 2008. PMID: 18178952

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

497 results

Search Page

Filters